EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 54 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $4,874,000 | -77.9% | 9,408 | -67.6% | 0.00% | – |
Q2 2020 | $22,013,000 | +11.3% | 29,079 | +50.0% | 0.00% | – |
Q1 2020 | $19,780,000 | +76.1% | 19,392 | +167.5% | 0.00% | – |
Q4 2019 | $11,234,000 | +102.6% | 7,248 | +136.6% | 0.00% | – |
Q3 2019 | $5,544,000 | – | 3,063 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 41,909,219 | $21,793,000 | 11.58% |
Kore Private Wealth LLC | 202,366 | $105,000 | 0.02% |
BARD ASSOCIATES INC | 335,750 | $175,000 | 0.02% |
HighTower Advisors, LLC | 5,284,688 | $2,738,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 126,529 | $66,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 654,200 | $339,000 | 0.01% |
Virtu Financial LLC | 57,076 | $30,000 | 0.01% |
MATRIX ASSET ADVISORS INC/NY | 39,500 | $20,000 | 0.00% |
NEXPOINT ASSET MANAGEMENT, L.P. | 33,933 | $18,000 | 0.00% |
WEDBUSH SECURITIES INC | 81,500 | $42,000 | 0.00% |